Daiichi Sankyo

Daiichi concludes acquisition process of Ranbaxy

Finally, Japan based drug maker Daiichi Sankyo has completed the acquisition process of Indian drug maker Ranbaxy Laboratories on Friday. The Japanese drug maker acquired remaining 11.4% stake for Rs 3,537.6 crore and its total stakes increased to 63.92%. 

Now, Daiichi has become the majority stake holder of the largest drug maker in the country. Singh family would still have some management roles in Ranbaxy. However, Ranbaxy would continue to work as an independent company.

Daiichi Sankyo acquires 52.5% stake of Ranbaxy

Japanese pharmaceutical major Daiichi Sankyo Co has informed that it has acquired 52.5% equity stake of India-based Ranbaxy Laboratories.

According to the sources, with the proposed acquisition, country’s largest pharmaceutical company Ranbaxy Laboratories has become an affiliate of Daiichi Sankyo.